Acura Pharmaceuticals files Form 8-K
Acura Pharmaceuticals filed a Form 8-K on November 3. The filing is for October 30.
Related stories
Intuitive Machines Secures Third NASA Contract in Six Months
The company will provide its spacecraft platform and system integration for NASA’s Falcon-Radar satellite. LUNR shares were up about 7% at the time of writing.
M impact | EQUITY | Nov 03, 2026, 03:32 PM UTC
Remedy Entertainment Reports Q3 Revenue of €39.6 Million, EBIT of €0.6 Million
The company said the results were driven by the launch of CONTROL Resonant, with more than one million copies sold by October 15, 2026. Remedy maintained its full-year revenue and
M impact | EQUITY | Nov 03, 2026, 03:32 PM UTC
Foreign investors buy ₹6,836.81 crore of Indian equities
FIIs recorded their largest single-day net investment of 2026 on Tuesday, November 3, according to exchange data. The inflow surpassed the previous 2026 high of ₹6,688.37 crore on
M impact | EQUITY | Nov 03, 2026, 03:31 PM UTC
Lattice Semiconductor shares surge
Lattice Semiconductor shares surged after its profit outlook exceeded market expectations.
M impact | EQUITY | Nov 03, 2026, 03:31 PM UTC
US session market picture: S&P 500 +0.33%, Nasdaq 100 +0.74%; EUR/USD -0.09%, WTI -0.01%, WBD leads volume
US session market picture. US index futures: S and P futures is up 0.33 percent, Nasdaq futures is up 0.74 percent, Dow futures is down 0.53 percent and Russell futures is up 0.69
M impact | EQUITY | Nov 03, 2026, 03:30 PM UTC
Optimus SBR Acquires Greenlight Consulting to Expand AI and Automation Capabilities
The acquisition is intended to expand capabilities for financial institutions, public sector organizations and healthcare.
M impact | EQUITY | Nov 03, 2026, 03:30 PM UTC